Latest news
Actinogen Medical Presents Xanamem Alzheimer's Data at Bioshares Biotech Summit - KalkineKalkine · Thu, 06 Aug 2026 02:54:16 GMTActinogen Medical’s Xanamem Alzheimer’s Treatment: 2026 Trial Update - Discovery AlertDiscovery Alert · Wed, 05 Aug 2026 15:35:10 GMTActinogen Medical targets Alzheimer’s treatment gap in projected $20BN market - Proactive InvestorsProactive Investors · Wed, 05 Aug 2026 01:50:00 GMTActinogen Medical advances pivotal XanaMIA trial towards November readout - ICYMI - Proactive financial newsProactive financial news · Sat, 01 Aug 2026 00:00:33 GMTActinogen Medical (ASX:ACW) Gains Momentum as Alzheimer’s Trial Progress and Regulatory Milestones Lift Investor Confidence - KalkineKalkine · Thu, 30 Jul 2026 07:00:00 GMTLightning Minerals sharpens Australian gold and tungsten focus after strategic reset - proactiveinvestors.com.auproactiveinvestors.com.au · Thu, 30 Jul 2026 01:33:00 GMTActinogen Medical keeps pivotal Alzheimer’s trial on track for November readout - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 30 Jul 2026 00:53:00 GMTActinogen Medical targets November XanaMIA results highlighting strong June quarter - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT